X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (308) 308
humans (216) 216
male (191) 191
mice (168) 168
female (154) 154
index medicus (123) 123
deoxyuridine - analogs & derivatives (107) 107
rats (105) 105
oncology (102) 102
deoxyuridine - metabolism (90) 90
pharmacology & pharmacy (74) 74
deoxyuridine - administration & dosage (67) 67
adult (65) 65
dose-response relationship, drug (64) 64
middle aged (57) 57
time factors (55) 55
deoxyuridine (46) 46
aged (45) 45
5-fluorouracil (43) 43
cells, cultured (39) 39
dna - biosynthesis (39) 39
dna (38) 38
deoxyuridine - pharmacology (37) 37
5-fluoro-2'-deoxyuridine (36) 36
apoptosis (35) 35
cancer (35) 35
cells (35) 35
cell proliferation (34) 34
proliferation (34) 34
5-bromo-2′-deoxyuridine (33) 33
administration, oral (33) 33
biochemistry & molecular biology (33) 33
5-bromo-2'-deoxyuridine (32) 32
thymidine - metabolism (32) 32
chemotherapy (31) 31
disease models, animal (28) 28
toxicology (28) 28
5-bromo-2 '-deoxyuridine (27) 27
bromodeoxyuridine (27) 27
expression (27) 27
immunohistochemistry (27) 27
rats, sprague-dawley (27) 27
5-iodo-2'-deoxyuridine (26) 26
deoxyuridine - therapeutic use (26) 26
rats, wistar (26) 26
cell division - drug effects (25) 25
idoxuridine - administration & dosage (25) 25
cell biology (24) 24
cell line, tumor (24) 24
drug synergism (24) 24
floxuridine - administration & dosage (24) 24
kinetics (24) 24
methotrexate - administration & dosage (24) 24
mice, inbred balb c (24) 24
mice, inbred c57bl (24) 24
tumor cells, cultured (24) 24
bromodeoxyuridine - administration & dosage (23) 23
injections, intraperitoneal (23) 23
neoplasms - drug therapy (23) 23
pharmacokinetics (23) 23
tritium (23) 23
bromodeoxyuridine - metabolism (22) 22
in-vivo (22) 22
liver - drug effects (22) 22
medicine, research & experimental (22) 22
research (22) 22
antimetabolites, antineoplastic - administration & dosage (21) 21
bromodeoxyuridine - analogs & derivatives (21) 21
fluorouracil - administration & dosage (21) 21
antineoplastic combined chemotherapy protocols - therapeutic use (20) 20
bone marrow - drug effects (20) 20
deoxyuridine - blood (20) 20
deoxyuridine - pharmacokinetics (20) 20
injections, intravenous (20) 20
methotrexate - pharmacology (20) 20
antiviral agents - administration & dosage (19) 19
article (19) 19
inhibition (19) 19
mice, inbred strains (19) 19
rabbits (19) 19
thymidine (19) 19
-5- (18) 18
antineoplastic agents - administration & dosage (18) 18
antineoplastic agents - pharmacology (18) 18
antiviral agents - therapeutic use (18) 18
cell proliferation - drug effects (18) 18
dna, neoplasm - biosynthesis (18) 18
nucleosides (18) 18
phosphorylation (18) 18
radiology, nuclear medicine & medical imaging (18) 18
research article (18) 18
thymidylate synthase - antagonists & inhibitors (18) 18
treatment outcome (18) 18
analysis (17) 17
apoptosis - drug effects (17) 17
bromodeoxyuridine - pharmacology (17) 17
cell division (17) 17
cell line (17) 17
deoxycytidine - analogs & derivatives (17) 17
drug administration schedule (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Surgical Oncology, ISSN 0022-4790, 03/2018, Volume 117, Issue 4, pp. 634 - 643
Journal Article
Cell Reports, ISSN 2211-1247, 06/2018, Volume 23, Issue 10, pp. 3031 - 3041
Telomerase, the end-replication enzyme, is reactivated in malignant cancers to drive cellular immortality. While this distinction makes telomerase an... 
POT1 | telomerase | 5-fluoro-2'-deoxyuridine | floxuridine | DNA damage | telomere | 5-fluoro-2’-deoxyuridine | APOPTOSIS | COMPLEX | RNA | PROTECTION | END | MECHANISMS | PROVIDES | BINDING | ATR | CELL BIOLOGY
Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 2/2006, Volume 7, Issue 1, pp. 13 - 29
Viral skin infections are common findings in organ transplant recipients. The most important etiological agents are the group of human herpesviruses (HHV),... 
Pharmacotherapy | Medicine & Public Health | Pharmacology/Toxicology | Dermatology | HUMAN HERPESVIRUS-6 | RENAL-ALLOGRAFT RECIPIENTS | KAPOSIS-SARCOMA | POLYMERASE CHAIN-REACTION | LYMPHOPROLIFERATIVE DISORDERS | HUMAN-HERPESVIRUS-8 INFECTION | HERPES-SIMPLEX VIRUS | EPSTEIN-BARR-VIRUS | HUMAN-PAPILLOMAVIRUS INFECTION | MOLLUSCUM-CONTAGIOSUM | DERMATOLOGY | Cytosine - analogs & derivatives | Humans | Cytosine - administration & dosage | Organ Transplantation | Trifluridine - administration & dosage | Molluscum Contagiosum - drug therapy | Molluscum Contagiosum - diagnosis | Valine - administration & dosage | Papillomavirus Infections - diagnosis | 2-Aminopurine - analogs & derivatives | 2-Aminopurine - administration & dosage | Skin Diseases, Viral - diagnosis | Drug Administration Schedule | Acyclovir - analogs & derivatives | Valine - analogs & derivatives | Herpesviridae Infections - diagnosis | Cytomegalovirus Infections - diagnosis | Antiviral Agents - administration & dosage | Epstein-Barr Virus Infections - drug therapy | Foscarnet - administration & dosage | Herpesviridae Infections - drug therapy | Organophosphonates - administration & dosage | Herpes Zoster - drug therapy | Cytomegalovirus Infections - drug therapy | Herpes Zoster - diagnosis | Papillomavirus Infections - drug therapy | Epstein-Barr Virus Infections - diagnosis | Immunocompromised Host | Acyclovir - administration & dosage | Skin Diseases, Viral - drug therapy
Journal Article
Cancer, ISSN 0008-543X, 09/2006, Volume 107, Issue 6, pp. 1383 - 1390
Journal Article
Investigational New Drugs, ISSN 0167-6997, 12/2015, Volume 33, Issue 6, pp. 1206 - 1216
Journal Article
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 6/2014, Volume 73, Issue 6, pp. 1205 - 1215
This Phase 1 study aimed to determine the recommended Phase 2 dose of LY2334737, an oral gemcitabine prodrug, when combined with standard dose docetaxel... 
Gemcitabine prodrug | Chemotherapy | Medicine & Public Health | Docetaxel | Oncology | Cancer Research | Phase 1 study | Solid tumors | Pharmacology/Toxicology | Pharmacokinetics | SOFT-TISSUE SARCOMAS | 2,2-DIFLUORODEOXYCYTIDINE | PACLITAXEL | PLUS DOCETAXEL | ONCOLOGY | DNA | METASTATIC BREAST-CANCER | SEQUENCE | PHARMACOLOGY & PHARMACY | Neoplasms - metabolism | Prodrugs - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Deoxyuridine - adverse effects | Deoxyuridine - pharmacokinetics | Dose-Response Relationship, Drug | Deoxycytidine - pharmacokinetics | Adult | Deoxycytidine - adverse effects | Female | Taxoids - adverse effects | Deoxycytidine - administration & dosage | Treatment Outcome | Neoplasms - drug therapy | Taxoids - pharmacokinetics | Prodrugs - adverse effects | Taxoids - administration & dosage | Deoxyuridine - analogs & derivatives | Prodrugs - pharmacokinetics | Aged | Neoplasms - pathology | Deoxyuridine - administration & dosage | Deoxycytidine - analogs & derivatives | Antimitotic agents | Complications and side effects | Care and treatment | Clinical trials | Dosage and administration | Antineoplastic agents | Tumors | Cancer | Index Medicus
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2011, Volume 17, Issue 18, pp. 6071 - 6082
Journal Article
Investigational New Drugs, ISSN 0167-6997, 4/2015, Volume 33, Issue 2, pp. 432 - 439
Journal Article
Neurosurgery, ISSN 0148-396X, 08/2005, Volume 57, Issue 2, pp. 266 - 279
Journal Article
15.